In vivo oxime administration does not influence Ellman acetylcholinesterase assay results

References

• Aas P. 2003. Future consideration for the medical management of nerve agent intoxication. Prehosp Disaster Med 18:208–216.
   PubMedGoogle Scholar
• Antonijevic B, Stojiljkovic MP. 2007. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 5:71–82.
   PubMedGoogle Scholar
• Bergner AD, O’Neill JJ. 1958. A modification of the Koelle technique for use with oximes. J Histochem Cytochem 6:72–74.
   PubMedGoogle Scholar
• Cohen EM, Wiersinga H. 1960. Oximes in the treatment of nerve gas poisoning. Acta Physiol Pharmacol 9:276–302.
   PubMedGoogle Scholar
• Dultz L, Epstein MA, Freeman G, Gray EH, Weil WB. 1957. Studies on a group of oximes as therapeutic compounds in sarin poisoning. J Pharmacol Exp Ther 119:522–531.
   PubMed Web of Science ®Google Scholar
• Ecobichon DJ. 2001. Toxic effects of pesticides. In: Klaassen CD (Ed.), Casarett and Doull’s Toxicology: the basic science of poisons. 6th ed. ed. C. D. Klaassen. New York: McGraw-Hill; pp. 763–810.
   Google Scholar
• Eddleston M, Dawson A, Karalliedde L, Dissanavake W, Hittarage A, Azher S, Buckley NA. 2004a. Early management after self-poisoning with an organophosphorus or carbamate pesticide—a treatment protocol for junior doctors. Crit Care 8:R391–R397.
   PubMed Web of Science ®Google Scholar
• Eddleston M, Singh S, Buckley N. 2004b. Organophosphorus poisoning (acute). Clin Evid 12:1941–1953.
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colormetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
   PubMed Web of Science ®Google Scholar
• Eyer P. 2003. The role of oximes in the management of organophosphate pesticide poisoning. Toxicol Rev 22:165–190.
   PubMedGoogle Scholar
• Green MD, Jones DE, Hilmas DE. 1985a. Sarin intoxication elevates plasma pralidoxime. Toxicol Lett 28:17–21.
   PubMedGoogle Scholar
• Green MD, Reid F, Kaminskis A. 1985b. Correlation of 2-PAM plasma levels after organophosphate intoxication. Res Commun Chem Pathol Pharmacol 49:255–266.
   PubMedGoogle Scholar
• Green MD, Talbot BG, Clark CR. 1986. Pharmacokinetics of pralidoxime chloride in the rat. Life Sci 39:2263–2269.
   PubMedGoogle Scholar
• Inns RH, Leadbeater L. 1983. The efficacy of bispyridium derivatives in the treatment of organophosphate poisoning in the guinea pig. J Pharm Pharmacol 35:427–433.
   PubMed Web of Science ®Google Scholar
• Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Lallement G, Clarencon D, Brochier G, Baubichon D, Galonnier M, Blanchet G, Mestries J-C. 1997. Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol Biochem Behav 56:325–332.
   PubMed Web of Science ®Google Scholar
• Marrs TC, Rice P, Vale JA. 2006. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297–323.
   PubMedGoogle Scholar
• Maxwell DM, Brecht KM, Lenz DE, O’Neill BL. 1988. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity. J Pharmacol Exp Ther 246:986–991.
   PubMed Web of Science ®Google Scholar
• Maxwell DM, Brecht KM, O’Neill BL. 1987. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett, 39:35–42.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Shih T-M. 1997. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathy. Neurosci Biobehav Rev 13:559–579.
   Google Scholar
• McDonough JH, Shih T-M, Kan R, Myers T, Koplovitz I. 2009. Therapeutic benefit of reactivation of sarin-inhibited acetylcholinesterase in the central nervous system by the tertiary oxime monoisonitrosoacetone in guinea pigs. Toxicologist 108:111.
   Google Scholar
• Moore DH, Clifford CB, Crawford IT, Cole GM, Baggett JM. 1995. Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In: Quinn DM, Balasubramanian AS, Doctor BP, Taylor P (Eds.), Enzymes of the cholinesterase family. New York: Plenum Press; pp. 297–304.
   Google Scholar
• Nadarajah B. 1992. The effect of pralidoxime chloride in the assay of acetylcholinesterase using 5,5’-dithio-bis(2-nitrobenzoic acid) (Ellman reagent). J Anal Toxicol 16:192–193.
   PubMedGoogle Scholar
• Pannbacker RG, Oehme FW. 2003. Pralidoxime hydrolysis of thiocholine esters. Vet Human Toxicol 45:39–40.
   PubMedGoogle Scholar
• Petroianu G, Missler A, Zuleger K, Thyes C, Ewald V, Maleck W. 2004. Enzyme reactivator treatment in organophosphate exposure: clinical relevance of thiocholinesteratic activity of pralidoxime. J Appl Toxicol 24:429–435.
   PubMedGoogle Scholar
• Petroianu GA. 2007. Letter to the Editor: Cholinesterase pseudo-activity, oximolysis, esterolysis, thiocholine ester hydrolysis by oximes: what’s in a name? Toxicol Lett 168:88–89.
   PubMed Web of Science ®Google Scholar
• Rutland JP. 1958. The effect of some oximes in sarin poisoning. Br J Pharmacol Chemother 13:399–403.
   PubMedGoogle Scholar
• Sakurada K, Ikegaya H, Ohta H, Akutsu T, Takatori T. 2006. Hydrolysis of an acetylthiocholine by pralidoxime iodide (2-PAM). Toxicol Lett 166:255–260.
   PubMedGoogle Scholar
• Saxena A, Luo C, Chilukuri N, Maxwell DM, Doctor BP. 2008. Novel approaches to medical protection against chemical warfare nerve agents. In: Romano JA, Lukey JA, Salem H (Eds.), Chemical warfare agents: Chemistry, pharmacology, toxicology and therapeutics. 2nd ed. Boca Raton, FL: CRC Press; pp. 145–173.
   Google Scholar
• Shih T–M. 1993. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 67:637–646.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Kan RK, McDonough JH. 2005. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact 157–158:293–303.
   Google Scholar
• Shih T-M, Skovira JW, O’Donnell JC, McDonough JH. 2007. Central cholinesterase reactivation by oximes improves survival and terminates seizures following nerve agent intoxication. Proceedings of the NATO HFM-149 Symposium on Defense Against the Effects of Chemical Toxic Hazards: Toxicology, Diagnosis and Medical Countermeasures, Edinburgh, Scotland, section 18:1–21.
   Google Scholar
• Shih T-M, Skovira JW, O’Donnell JC, McDonough JH. 2009. Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. J Mol Neurosci; DOI:10.1007/s12031-009-9259-7.
   Google Scholar
• Shih T-M, Whalley CE, Valdes JJ. 1991. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol Lett 55:131–147.
   PubMed Web of Science ®Google Scholar
• Simons KJ, Briggs CJ. 1985. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration. J Pharm Pharmacol 37:367–369.
   PubMedGoogle Scholar
• Singh H, Moorad-Doctor D, Ratcliffe RH, Wachtel K, Castillo A, Garcia GE. 2007. A rapid cation-exchange HPLC method for detection and quantification of pyridinium oximes in plasma and tissue. J Anal Toxicol 31:69–74.
   PubMedGoogle Scholar
• Sinko G, Calic M, Bosak A, Kovarik Z. 2007. Limitation of the Ellman method: cholinesterase activity measurement in the presence of oximes. Anal Biochem 370:223–227.
   PubMed Web of Science ®Google Scholar
• Skrinjarik-Spoljar M, Kralj M. 1980. Reactivating and protective effects of pyridinium compounds in human erythrocyte acetylcholinesterase inhibition by organophosphates in vitro. Arch Toxicol 45:21–27.
   PubMedGoogle Scholar
• Taylor P. 2001. Anticholinesterase agents, In: Hardman JG, Limbird LE, Gilman AG (Eds.), Goodman and Gilman’s The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; pp. 175–191.
   Google Scholar
• Vallejo-Freire AA. 1951. A simple technique for repeated collection of blood samples from guinea pigs. Science 114:524–525.
   PubMed Web of Science ®Google Scholar
• Wilson IB, Ginsburg S. 1955. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim Biophys Acta 18:168–170.
   PubMed Web of Science ®Google Scholar
• Worek F, Eyer P. 2006. Letter to the editor. Toxicol Lett 167:256–257.
   PubMedGoogle Scholar